3-(4-Chloro-benzyl)-8-hydroxy-1,2,3,4-tetrahydro-chromeno[3,4-c]pyridin-5-one

ID: ALA314095

PubChem CID: 10042972

Max Phase: Preclinical

Molecular Formula: C19H16ClNO3

Molecular Weight: 341.79

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1oc2cc(O)ccc2c2c1CN(Cc1ccc(Cl)cc1)CC2

Standard InChI:  InChI=1S/C19H16ClNO3/c20-13-3-1-12(2-4-13)10-21-8-7-15-16-6-5-14(22)9-18(16)24-19(23)17(15)11-21/h1-6,9,22H,7-8,10-11H2

Standard InChI Key:  DTSBUYTYJIUAIH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
    5.5667   -5.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8500   -5.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5667   -6.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8500   -6.9792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1375   -6.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1375   -5.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2792   -4.5000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2792   -5.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8500   -4.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4250   -6.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4250   -5.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2875   -6.9917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5625   -4.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0042   -4.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7042   -6.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7042   -5.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0125   -3.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0125   -1.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0125   -0.7667    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.3000   -2.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7292   -2.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3000   -2.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7292   -2.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9917   -6.9792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  3  1  0
  5  4  1  0
  6  2  1  0
  7  8  1  0
  8  1  1  0
  9  2  1  0
 10  5  2  0
 11  6  2  0
 12  3  2  0
 13  7  1  0
 14  7  1  0
 15 10  1  0
 16 11  1  0
 17 14  1  0
 18 21  2  0
 19 18  1  0
 20 22  2  0
 21 23  1  0
 22 17  1  0
 23 17  2  0
 24 15  1  0
  5  6  1  0
 13  9  1  0
 15 16  2  0
 18 20  1  0
M  END

Associated Targets(Human)

DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine receptors; D2 & D4 (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 341.79Molecular Weight (Monoisotopic): 341.0819AlogP: 3.71#Rotatable Bonds: 2
Polar Surface Area: 53.68Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.79CX Basic pKa: 6.66CX LogP: 3.20CX LogD: 3.21
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.72Np Likeness Score: -0.42

References

1. Unangst PC, Capiris T, Connor DT, Heffner TG, MacKenzie RG, Miller SR, Pugsley TA, Wise LD..  (1997)  Chromeno[3,4-c]pyridin-5-ones: selective human dopamine D4 receptor antagonists as potential antipsychotic agents.,  40  (17): [PMID:9276014] [10.1021/jm970170v]
2. Salehian F, Nadri H, Jalili-Baleh L, Youseftabar-Miri L, Abbas Bukhari SN, Foroumadi A, Tüylü Küçükkilinç T, Sharifzadeh M, Khoobi M..  (2021)  A review: Biologically active 3,4-heterocycle-fused coumarins.,  212  [PMID:33276991] [10.1016/j.ejmech.2020.113034]

Source